newsfilter
← Latest News
PR Newswire·

ADC Therapeutics Announces ZYNLONTA® Updates in Japan

Licensing partner, Tanabe Pharma, filed for Japanese approval of ZYNLONTA (MT-2111) for relapsed or refractory DLBCL based on encouraging Japanese Phase 1/2 clinical resultsTanabe Pharma entered into exclusive